J. Rose and M. Whitt, Rhabdoviridae: the viruses and their replication

G. Letchworth, L. Rodriguez, D. Cbarrera, and J. , Vesicular Stomatitis, The Veterinary Journal, vol.157, issue.3, pp.239-60, 1999.
DOI : 10.1053/tvjl.1998.0303

B. Lichty, A. Power, D. Stojdl, and J. Bell, Vesicular stomatitis virus: re-inventing the bullet, Trends in Molecular Medicine, vol.10, issue.5, pp.211-218, 2004.
DOI : 10.1016/j.molmed.2004.03.003

S. Libersou, A. Albertini, and M. Ouldali, Distinct structural rearrangements of the VSV glycoprotein drive membrane fusion, The Journal of Cell Biology, vol.54, issue.1, pp.199-210, 2010.
DOI : 10.1083/jcb.201006116.dv

D. Cureton, R. Massol, and S. Saffarian, Vesicular Stomatitis Virus Enters Cells through Vesicles Incompletely Coated with Clathrin That Depend upon Actin for Internalization, PLoS Pathogens, vol.94, issue.12, p.1000394, 2009.
DOI : 10.1371/journal.ppat.1000394.s012

A. Albertini, E. Baquero, A. Ferlin, and Y. Gaudin, Molecular and Cellular Aspects of Rhabdovirus Entry, Viruses, vol.4, issue.12, pp.117-156, 2012.
DOI : 10.3390/v4010117

S. Roche, F. Rey, Y. Gaudin, and S. Bressanelli, Structure of the Prefusion Form of the Vesicular Stomatitis Virus Glycoprotein G, Science, vol.315, issue.5813, pp.843-851, 2007.
DOI : 10.1126/science.1135710

URL : https://hal.archives-ouvertes.fr/hal-00167649

H. Jayakar, E. Jeetendra, and M. Whitt, Rhabdovirus assembly and budding, Virus Research, vol.106, issue.2, pp.117-149, 2004.
DOI : 10.1016/j.virusres.2004.08.009

X. Zhang, T. Green, and J. Tsao, Role of Intermolecular Interactions of Vesicular Stomatitis Virus Nucleoprotein in RNA Encapsidation, Journal of Virology, vol.82, issue.2, pp.674-82, 2008.
DOI : 10.1128/JVI.00935-07

D. Lyles, M. Mckenzie, and P. Kaptur, Complementation of M Gene Mutants of Vesicular Stomatitis Virus by Plasmid-Derived M Protein Converts Spherical Extracellular Particles into Native Bullet Shapes, Virology, vol.217, issue.1, pp.76-87, 1996.
DOI : 10.1006/viro.1996.0095

S. Balachandran and G. Barber, Defective translational control facilitates vesicular stomatitis virus oncolysis, Cancer Cell, vol.5, issue.1, pp.51-65, 2004.
DOI : 10.1016/S1535-6108(03)00330-1

URL : http://doi.org/10.1016/s1535-6108(03)00330-1

G. Stark, I. Kerr, and B. Williams, HOW CELLS RESPOND TO INTERFERONS, Annual Review of Biochemistry, vol.67, issue.1, pp.227-64, 1998.
DOI : 10.1146/annurev.biochem.67.1.227

P. Wongthida, R. Diaz, and F. Galivo, VSV Oncolytic Virotherapy in the B16 Model Depends Upon Intact MyD88 Signaling, Molecular Therapy, vol.19, issue.1, pp.150-158, 2011.
DOI : 10.1038/mt.2010.225

P. Georgel, Z. Jiang, and S. Kunz, Vesicular stomatitis virus glycoprotein G activates a specific antiviral Toll-like receptor 4-dependent pathway, Virology, vol.362, issue.2, pp.304-317, 2007.
DOI : 10.1016/j.virol.2006.12.032

M. Ahmed, L. Mitchell, and S. Puckett, Vesicular Stomatitis Virus M Protein Mutant Stimulates Maturation of Toll-Like Receptor 7 (TLR7)-Positive Dendritic Cells through TLR-Dependent and -Independent Mechanisms, Journal of Virology, vol.83, issue.7, pp.2962-75, 2009.
DOI : 10.1128/JVI.02030-08

G. Dock, THE INFLUENCE OF COMPLICATING DISEASES UPON LEUK??MIA.*, The American Journal of the Medical Sciences, vol.127, issue.4, pp.563-92, 1904.
DOI : 10.1097/00000441-190412740-00001

G. Lemay, Apprivoiser nos ennemis pour en faire des alli??s??: la ????viroth??rapie???? anticanc??reuse, m??decine/sciences, vol.28, issue.4, pp.339-379, 2012.
DOI : 10.1051/medsci/2012284001

E. Kelly, R. Nace, G. Barber, and S. Russell, Attenuation of Vesicular Stomatitis Virus Encephalitis through MicroRNA Targeting, Journal of Virology, vol.84, issue.3, pp.1550-62, 2010.
DOI : 10.1128/JVI.01788-09

J. Qiao, T. Kottke, and C. Willmon, Purging metastases in lymphoid organs using a combination of antigen-nonspecific adoptive T cell therapy, oncolytic virotherapy and immunotherapy, Nature Medicine, vol.62, issue.1, pp.37-44, 2008.
DOI : 10.1016/0092-8674(94)90169-4

K. Doronin, E. Shashkova, and S. May, Chemical Modification with High Molecular Weight Polyethylene Glycol Reduces Transduction of Hepatocytes and Increases Efficacy of Intravenously Delivered Oncolytic Adenovirus, Human Gene Therapy, vol.20, issue.9, pp.975-88, 2009.
DOI : 10.1089/hum.2009.028

P. Génin, R. Lin, J. Hiscott, and A. Civas, Recruitment of Histone Deacetylase 3 to the Interferon-A Gene Promoters Attenuates Interferon Expression, PLoS ONE, vol.107, issue.6, p.38336, 2012.
DOI : 10.1371/journal.pone.0038336.s004

G. Fulci, L. Breymann, and D. Gianni, Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses, Proceedings of the National Academy of Sciences, vol.103, issue.34, pp.12873-12881, 2006.
DOI : 10.1073/pnas.0605496103

L. Boeuf, F. Diallo, J. Mccart, and J. , Synergistic Interaction Between Oncolytic Viruses Augments Tumor Killing, Molecular Therapy, vol.18, issue.5, pp.888-95, 2010.
DOI : 10.1038/mt.2010.44

Z. Guo, S. Thorne, and D. Bartlett, Oncolytic virotherapy: Molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol.1785, issue.2, pp.217-248, 2008.
DOI : 10.1016/j.bbcan.2008.02.001

X. Fu and X. Zhang, Potent systemic antitumor activity from an oncolytic herpes simplex virus of syncytial phenotype, Cancer Res, vol.62, pp.2306-2318, 2002.

P. Msaouel, A. Dispenzieri, and E. Galanis, Clinical testing of engineered oncolytic measles virus strains in the treatment of cancer: an overview, Curr Opin Mol Ther, vol.11, pp.43-53, 2009.

S. Ries and W. Korn, ONYX-015: mechanisms of action and clinical potential of a replication-selective adenovirus, British Journal of Cancer, vol.254, issue.1, pp.5-11, 2002.
DOI : 10.1038/357082a0

C. Breitbach, J. Burke, and D. Jonker, Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans, Nature, vol.183, issue.7362, pp.99-102, 2011.
DOI : 10.1038/nature10358

Y. Touchefeu, U. Schick, and K. Harrington, Le virus de la rougeole, m??decine/sciences, vol.28, issue.4, pp.388-94, 2012.
DOI : 10.1051/medsci/2012284016

E. Galanis, S. Markovic, and V. Suman, Phase II Trial of Intravenous Administration of Reolysin?? (Reovirus Serotype-3-dearing Strain) in Patients with Metastatic Melanoma, Molecular Therapy, vol.20, issue.10, pp.1998-2003, 2012.
DOI : 10.1038/mt.2012.146

L. Apetoh, F. Ghiringelli, and L. Zitvogel, La calr??ticuline d??termine l???immunog??nicit?? de la chimioth??rapie et de la radioth??rapie antitumorales, m??decine/sciences, vol.23, issue.3, pp.257-265, 2007.
DOI : 10.1051/medsci/2007233257

J. Pol, L. Boeuf, F. Diallo, and J. , Strat??gies g??n??tiques, immunologiques et pharmacologiques au service d???une nouvelle g??n??ration de virus anticanc??reux, m??decine/sciences, vol.29, issue.2, p.29
DOI : 10.1051/medsci/2013292014

B. Dancho, M. Mckenzie, J. Connor, and D. Lyles, Vesicular Stomatitis Virus Matrix Protein Mutations That Affect Association with Host Membranes and Viral Nucleocapsids, Journal of Biological Chemistry, vol.284, issue.7, pp.4500-4509, 2009.
DOI : 10.1074/jbc.M808136200

B. Mccreedy and D. Lyles, Distribution of M protein and nucleocapsid protein of vesicular stomatitis virus in infected cell plasma membranes, Virus Research, vol.14, issue.3, pp.189-205, 1989.
DOI : 10.1016/0168-1702(89)90001-4

D. Blondel, G. Harmison, and M. Schubert, Role of matrix protein in cytopathogenesis of vesicular stomatitis virus, J Virol, vol.64, pp.1716-1741, 1990.

R. Melki, Y. Gaudin, and D. Blondel, Interaction between Tubulin and the Viral Matrix Protein of Vesicular Stomatitis Virus: Possible Implications in the Viral Cytopathic Effect, Virology, vol.202, issue.1, pp.339-386, 1994.
DOI : 10.1006/viro.1994.1350

M. Ahmed and D. Lyles, Effect of vesicular stomatitis virus matrix protein on transcription directed by host RNA polymerases I, II, and III, J Virol, vol.72, pp.8413-8422, 1998.

J. Connor and D. Lyles, Vesicular Stomatitis Virus Infection Alters the eIF4F Translation Initiation Complex and Causes Dephosphorylation of the eIF4E Binding Protein 4E-BP1, Journal of Virology, vol.76, issue.20, pp.10177-87, 2002.
DOI : 10.1128/JVI.76.20.10177-10187.2002

J. Petersen, L. Her, and V. Varvel, The Matrix Protein of Vesicular Stomatitis Virus Inhibits Nucleocytoplasmic Transport When It Is in the Nucleus and Associated with Nuclear Pore Complexes, Molecular and Cellular Biology, vol.20, issue.22, pp.8590-601, 2000.
DOI : 10.1128/MCB.20.22.8590-8601.2000

D. Stojdl, B. Lichty, and B. Tenoever, VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents, Cancer Cell, vol.4, issue.4, pp.263-75, 2003.
DOI : 10.1016/S1535-6108(03)00241-1

A. Garcia-sastre and C. Biron, Type 1 Interferons and the Virus-Host Relationship: A Lesson in Detente, Science, vol.312, issue.5775, pp.879-82, 2006.
DOI : 10.1126/science.1125676

M. Ahmed, M. Mckenzie, and S. Puckett, Ability of the Matrix Protein of Vesicular Stomatitis Virus To Suppress Beta Interferon Gene Expression Is Genetically Correlated with the Inhibition of Host RNA and Protein Synthesis, Journal of Virology, vol.77, issue.8, pp.4646-57, 2003.
DOI : 10.1128/JVI.77.8.4646-4657.2003

P. Ge, J. Tsao, and S. Schein, Cryo-EM Model of the Bullet-Shaped Vesicular Stomatitis Virus, Science, vol.327, issue.5966, pp.689-93, 2010.
DOI : 10.1126/science.1181766

M. Hoffmann, Y. Wu, and M. Gerber, Fusion-active glycoprotein G mediates the cytotoxicity of vesicular stomatitis virus M mutants lacking host shut-off activity, Journal of General Virology, vol.91, issue.11, pp.2782-93, 2010.
DOI : 10.1099/vir.0.023978-0

G. Wollmann, V. Rogulin, and I. Simon, Some Attenuated Variants of Vesicular Stomatitis Virus Show Enhanced Oncolytic Activity against Human Glioblastoma Cells relative to Normal Brain Cells, Journal of Virology, vol.84, issue.3, pp.1563-73, 2010.
DOI : 10.1128/JVI.02040-09

A. Francoeur, L. Poliquin, and C. Stanners, The isolation of interferon-inducing mutants of vesicular stomatitis virus with altered viral P function for the inhibition of total protein synthesis, Virology, vol.160, issue.1, pp.236-281, 1987.
DOI : 10.1016/0042-6822(87)90065-1

V. Janelle, F. Brassard, and P. Lapierre, Mutations in the Glycoprotein of Vesicular Stomatitis Virus Affect Cytopathogenicity: Potential for Oncolytic Virotherapy, Journal of Virology, vol.85, issue.13, pp.6513-6533, 2011.
DOI : 10.1128/JVI.02484-10

URL : https://hal.archives-ouvertes.fr/pasteur-00722467

S. Kopeky, M. Wiillingham, and D. Lyles, Matrix Protein and Another Viral Component Contribute to Induction of Apoptosis in Cells Infected with Vesicular Stomatitis Virus, Journal of Virology, vol.75, issue.24, pp.12169-81, 2001.
DOI : 10.1128/JVI.75.24.12169-12181.2001

M. Desforges, G. Despars, and S. Bérard, Matrix Protein Mutations Contribute to Inefficient Induction of Apoptosis Leading to Persistent Infection of Human Neural Cells by Vesicular Stomatitis Virus, Virology, vol.295, issue.1, pp.63-73, 2002.
DOI : 10.1006/viro.2001.1329

A. Bateman, F. Bullough, and S. Murphy, Fusogenic membrane glycoproteins as a novel class of genes for the local and immune-mediated control of tumor growth, Cancer Res, vol.60, pp.1492-1499, 2000.

H. Higuchi, S. Bronk, and A. Bateman, Viral fusogenic membrane glycoprotein expression causes syncytia formation with bioenergetic cell death: implications for gene therapy, Cancer Res, vol.60, pp.6396-402, 2000.

V. Phan, F. Errington, and S. Cheong, A new genetic method to generate and isolate small, short-lived but highly potent dendritic cell-tumor cell hybrid vaccines, Nature Medicine, vol.9, issue.9, pp.1215-1224, 2003.
DOI : 10.1038/nm923

A. Danen-van-oorschot, D. Fischer, and J. Grimbergen, Apoptin induces apoptosis in human transformed and malignant cells but not in normal cells, Proceedings of the National Academy of Sciences, vol.94, issue.11, pp.5843-5850, 1997.
DOI : 10.1073/pnas.94.11.5843

M. Burek, S. Maddika, and C. Burek, Apoptin-induced cell death is modulated by Bcl-2 family members and is Apaf-1 dependent, Oncogene, vol.16, issue.15, pp.2213-2235, 2005.
DOI : 10.1038/sj.onc.1209258

D. Stojdl, B. Lichty, and S. Knowles, Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus, Nat Med, vol.6, pp.821-826, 2000.

M. Desforges, J. Charron, and S. Bérard, Different host-cell shutoff strategies related to the matrix protein lead to persistence of vesicular stomatitis virus mutants on fibroblast cells, Virus Research, vol.76, issue.1, pp.87-102, 2001.
DOI : 10.1016/S0168-1702(01)00251-9

S. Balachandran and G. Barber, Vesicular Stomatitis Virus (VSV) Therapy of Tumors, IUBMB Life, vol.50, issue.2, pp.135-143, 2000.
DOI : 10.1080/713803696